Filing Details
- Accession Number:
- 0001127602-17-032436
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-16 17:24:18
- Reporting Period:
- 2017-11-16
- Accepted Time:
- 2017-11-16 17:24:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
310142 | Sensient Technologies Corp | SXT | Industrial Organic Chemicals (2860) | 390561070 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1200336 | Essie Whitelaw | 777 East Wisconsin Avenue Milwaukee WI 53202 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-16 | 667 | $30.07 | 16,691 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-16 | 667 | $75.15 | 16,024 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2017-11-16 | 667 | $0.00 | 667 | $30.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-05-01 | 2018-05-01 | No | 4 | M | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Deferred Stock | $0.00 | 739 | 739 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
739 | 739 | Direct |
Footnotes
- Exercise of in-the-money stock option that would otherwise expire on 5/1/2018, exempt from Section 16(b) by virtue of Rule 16b-6(b) and Rule 16b-3(d) and (e).
- Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan.
- Original option grant vests in three equal annual installments beginning on the date listed in the "Date Exercisable" column.
- Deferred stock converts to common stock on a one-for-one basis.
- Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.